Cellebrite Market Capitalization from 2010 to 2024

CLBT Stock  USD 20.40  0.04  0.20%   
Cellebrite Market Cap yearly trend continues to be comparatively stable with very little volatility. Market Cap will likely drop to about 1.6 B in 2024.
Check Cellebrite financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellebrite's main balance sheet or income statement drivers, such as Tax Provision of 4 M, Interest Income of 8.4 M or Depreciation And Amortization of 8 M, as well as many indicators such as Price To Sales Ratio of 6.58, Dividend Yield of 0.0818 or PTB Ratio of 50.54. Cellebrite financial statements analysis is a perfect complement when working with Cellebrite Valuation or Volatility modules.
  
Check out the analysis of Cellebrite Correlation against competitors.

Latest Cellebrite's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Cellebrite DI over the last few years. It is Cellebrite's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellebrite's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 4.38 B10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Cellebrite Market Capitalization Regression Statistics

Arithmetic Mean1,713,617,999
Geometric Mean1,699,407,850
Coefficient Of Variation12.23
Mean Deviation149,926,718
Median1,808,049,922
Standard Deviation209,584,537
Sample Variance43925.7T
Range738.8M
R-Value(0.43)
Mean Square Error38388.5T
R-Squared0.19
Significance0.11
Slope(20,345,993)
Total Sum of Squares614959.5T

Cellebrite Market Capitalization History

20241.6 B
20231.9 B
20221.6 B
20211.2 B
20201.3 B

About Cellebrite Financial Statements

Cellebrite shareholders use historical fundamental indicators, such as Market Capitalization, to determine how well the company is positioned to perform in the future. Although Cellebrite investors may analyze each financial statement separately, they are all interrelated. The changes in Cellebrite's assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellebrite's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation. Cellebrite operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 900 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellebrite Stock Analysis

When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.